BSEBoard Meeting29 Jul 2026 · 29 Jul 2026, 05:29 pm

Jenburkt Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve standalone unaudited ....

Jenburkt Pharmaceuticals Ltd · 524731

✦ AI SummaryResults

Jenburkt Pharmaceuticals Ltd has scheduled a Board Meeting on 06/08/2026 to consider and approve standalone unaudited financial results for the quarter ended 30/06/2026.

Analysis Scores

Earnings Impact5/10

Growth Catalyst2/10

Governance Concern1/10

Regulatory Risk1/10

Balance Sheet Risk1/10

Liquidity Impact5/10

Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

Full Announcement

Jenburkt Pharmaceuticals Ltd - 524731 - Board Meeting Intimation for Considering And Approving Standalone Unaudited Financial Results For The Quarter Ended On 30Th June, 2026.

Attachments (1)

📄

c2d60473-bd3f-4c97-b955-4cf1b73d7c6e.pdf

pdf

Download →

View document text

Ref. No.: JPL/CS/2325/2026 Date: 29th July, 2026. BSE Ltd., Phiroze Jeejeebhoy Towers, Dalal Street,Fort, Mumbai - 400 001. Script Code :524731 Sub. : Board Meeting. Reg.: Intimation under Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015. Dear Sir, In continuation to our letter No. JPL/CS/2317/2026 dated 18th June, 2026, kindly note that with reference to the captioned regulation, a Meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 06th August, 2026, at Nirmala Apartments, 93, Jay Prakash Road, Andheri (West), Mumbai-400 058, inter-alia, to take on record the standalone unaudited financial results of the Company for the quarter ended on 30th June, 2026. Kindly take on record the above. Thanking you, Yours faithfully, For Jenburkt Pharmaceuticals Limited, Ashish R. Shah Sr. VP and Company Secretary and Compliance Officer.